Figure 3From: Effect of empagliflozin monotherapy on postprandial glucose and 24-hour glucose variability in Japanese patients with type 2 diabetes mellitus: a randomized, double-blind, placebo-controlled, 4-week study Change from baseline in FPG at day 2 and day 29 based on analyses of covariance in the full analysis set. CI, confidence interval; FPG, fasting plasma glucose; SE, standard error.Back to article page